SANDRA GURROLA

Profile

First Name

: SANDRA

Middle Name

:

Last Name

: GURROLA

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
BROOKLYN IMMUNOTHERAPEUTICS, INC.
MATTHEW ANGEL, TERRY BATEMAN, JEFF BERG, KENDRA BERGER, BRANT BINDER, JAMES BRISTOL, BARRY CHANDLER, CHARLES CHERINGTON, PETER CICALA, DOROTHY CLARKE, KEVIN D-AMOUR, ERIN S. ENRIGHT, JOSEPH J. FARRICIELLI, JR., HOWARD J. FEDEROFF, GREGORY FIORE, ANDREW JACKSON, KENNETH L. KEYMER, VLADIMIR KHUCHUA-EDELMAN, DENNIS LANGER, MARY BETH LEWIS, SANJEEV LUTHER, STEVE MITGANG, ERICH MOHR, KIRK NAGAMINE, ELENA RATNER, HEATHER B. REDMAN, JAY SIAL, ROGER SIDHU, NICHOLAS J. SINGER, TONY UPHOFF, RICHARD W. WAGNER, WILLIAM WEXLER, PAUL YANOVER
EXECUTIVE OFFICER
ETERNA THERAPEUTICS INC.
MATTHEW ANGEL, TERRY BATEMAN, JEFF BERG, KENDRA BERGER, BRANT BINDER, JAMES BRISTOL, BARRY CHANDLER, CHARLES CHERINGTON, PETER CICALA, DOROTHY CLARKE, KEVIN D-AMOUR, ERIN S. ENRIGHT, JOSEPH J. FARRICIELLI, JR., HOWARD J. FEDEROFF, GREGORY FIORE, ANDREW JACKSON, KENNETH L. KEYMER, VLADIMIR KHUCHUA-EDELMAN, DENNIS LANGER, MARY BETH LEWIS, SANJEEV LUTHER, STEVE MITGANG, ERICH MOHR, KIRK NAGAMINE, ELENA RATNER, HEATHER B. REDMAN, JAY SIAL, ROGER SIDHU, NICHOLAS J. SINGER, TONY UPHOFF, RICHARD W. WAGNER, WILLIAM WEXLER, PAUL YANOVER
EXECUTIVE OFFICER
ERNEXA THERAPEUTICS INC.
MATTHEW ANGEL, TERRY BATEMAN, JEFF BERG, KENDRA BERGER, BRANT BINDER, JAMES BRISTOL, BARRY CHANDLER, CHARLES CHERINGTON, PETER CICALA, DOROTHY CLARKE, KEVIN D-AMOUR, ERIN S. ENRIGHT, JOSEPH J. FARRICIELLI, JR., HOWARD J. FEDEROFF, GREGORY FIORE, ANDREW JACKSON, KENNETH L. KEYMER, VLADIMIR KHUCHUA-EDELMAN, DENNIS LANGER, MARY BETH LEWIS, SANJEEV LUTHER, STEVE MITGANG, ERICH MOHR, KIRK NAGAMINE, ELENA RATNER, HEATHER B. REDMAN, JAY SIAL, ROGER SIDHU, NICHOLAS J. SINGER, TONY UPHOFF, RICHARD W. WAGNER, WILLIAM WEXLER, PAUL YANOVER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-04-11
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2025-03-31 
2024-11-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2024-09-24 
2024-11-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Debt 
2024-09-24 
2023-12-20
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity, Debt 
2023-12-15 
2023-07-26
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2023-07-14 
2023-07-26
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2023-07-14 
2022-12-16
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-12-02 
2022-03-23
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-03-09